GENE ONLINE|News &
Opinion
Blog

2020-08-19| R&DSpecialTechnology

A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy

by Ruchi Jhonsa
Share To
Washington University School of Medicine researchers uncover the mechanism by which tumor-infiltrating myeloid cells create suppressive microenvironments. The findings provide a novel approach for augmenting the effects of checkpoint blockade therapies. The suppressive tumor environment affects T cell responses by engaging immune checkpoint proteins such as PD-1.

GO Prime with only $1.49 now

LATEST
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
Unveiling the Role of Microbes in Climate Change at COP28
2023-12-04
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
EVENT
Scroll to Top